Jessica Konen, PhD, is an instructor in the Department of Hematology and Medical Oncology at Emory University School of Medicine.
Dr. Konen is a member of the Cancer Immunology Research Program at Winship Cancer Institute of Emory University. She holds professional membership with American Association for Cancer Research and Society for Immunotherapy of Cancer.
Education
Dr. Konen earned her PhD from Emory University in Atlanta, Georgia. She completed her postdoctoral training at The University of Texas MD Anderson Cancer Center in Houston, Texas.
Titles & Roles
Instructor, Department of Hematology and Medical Oncology
Emory University School of Medicine
Research
Dr. Konen's research focuses on revealing intrinsic and acquired resistance mechanisms to immunotherapy in lung cancer patients, with a focus on implementing rational drug combinations to improve immune checkpoint blockade efficacy. Her research efforts have revealed the importance of bioactive metabolites within the tumor microenvironment that can alter T cell functionality and thus response to immunotherapy. Using multi-modal approaches, her research aims to continue to dissect the extracellular metabolome during "normal" lung cancer evolution, as well as explore how immunotherapy-resistant tumor cells alter this profile over time to generate immune dysfunction.
BL Rodriguez, L Chen, Y Li, S Miao, DH Peng, JJ Fradette, L Diao, JM Konen, FRR Alvarez, LM Solis, X Yi, A Padhye, LA Gibson, JK Ochieng, X Zhou, J Wang, DL Gibbons
